Marcadia Biotech
317.566.2266
Contact Us
Home
About Us
Overview
Executive Management
Scientific Advisory Board
Board of Directors
Partners
Discovery Partners
Strategic Partners
Investors
Scientific Focus
Diabetes & Obesity
GLP-1
GIP
Glucagon
Development Programs
Pipeline
GIP/GLP-1 Dual Agonist
Ready-to-Use Glucagon (Lilly Collaboration)
Merck Collaboration
Technology & Capabilities
News
Press Releases
In the News
Media
Resources
Resources
If you would like to know more about diabetes, please visit any of the following resources:
For obesity / other metabolic diseases, visit:
Information regarding Indiana life science/health initiatives is available at:
Resources
Press Releases
Marcadia and Lilly Sign Development, License Agreement
Marcadia Biotech Board of Directors Appointment
Novel Therapeutic Candidate Targets Two Incretin Hormone Receptors
Read All Releases
Development Programs
Pipeline
GIP/GLP-1 Dual Agonist
Ready-to-Use Glucagon (Lilly Collaboration)
Merck Collaboration
Technology & Capabilities